Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma

Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma

For years, prospective randomized clinical trials excluded patients with non-conventional histologies of renal cell carcinoma (RCC). The paucity of data has led to adopting the same treatment strategies used for clear-cell RCC (ccRCC). In the present narrative review, we explored state of the art ab...

Full description

Bibliographic Details
Main Authors: Melissa Bersanelli, Sara Elena Rebuzzi, Giandomenico Roviello, Martina Catalano, Matteo Brunelli, Mimma Rizzo
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
non-clear cell renal carcinoma
nccrcc
immune checkpoint inhibitors
anti-pd-1
papillary renal cell carcinoma
chromophobe renal cell carcinoma
mitf translocation
collecting duct carcinoma
sarcomatoid rcc
kidney cancer
Online Access:http://dx.doi.org/10.1080/21645515.2023.2171672

Internet

http://dx.doi.org/10.1080/21645515.2023.2171672

Similar Items